Neurobehavioral characterization of APP23 transgenic mice with the SHIRPA primary screen.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Behavioural Brain Research

• Publication date

  2005-02-10

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.BBR.2004.06.020PMID 15617775
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterization of NFH-LacZ transgenic mice with the SHIRPA primary screening battery and tests of motor coordination, exploratory activity, and spatial learning.

  2003cited by this paper
• Age‐dependent cognitive decline in the APP23 model precedes amyloid deposition

  2003cited by this paper
• Transgenic mice expressing the βAPP695SWE mutation: effects on exploratory activity, anxiety, and motor coordination

  2003cited by this paper
• Regional brain cytochrome oxidase activity in beta-amyloid precursor protein transgenic mice with the Swedish mutation.

  2003cited by this paper
• Transgenic mice expressing the PS1-A246E mutation: effects on spatial learning, exploration, anxiety, and motor coordination.

  2003cited by this paper
• Progressive age-related impairment of cognitive behavior in APP23 transgenic mice.

  2003cited by this paper
• Neuropeptide alterations in the hippocampal formation and cortex of transgenic mice overexpressing beta-amyloid precursor protein (APP) with the Swedish double mutation (APP23).

  2003cited by this paper
• Compromised Hemodynamic Response in Amyloid Precursor Protein Transgenic Mice

  2002cited by this paper
• Amyloid-Associated Neuron Loss and Gliogenesis in the Neocortex of Amyloid Precursor Protein Transgenic Mice

  2002cited by this paper
• Spatial learning, exploration, anxiety, and motor coordination in female APP23 transgenic mice with the Swedish mutation.

  2002cited by this paper
• Cholinergic Changes in the APP23 Transgenic Mouse Model of Cerebral Amyloidosis

  2002cited by this paper
• The Mutant Mouse Behaviour network, a medium to present and discuss methods for the behavioural phenotyping.

  2001cited by this paper
• Comparative Analysis of Amyloid-β Chemical Structure and Amyloid Plaque Morphology of Transgenic Mouse and Alzheimer's Disease Brains*

  2001cited by this paper
• SHIRPA, a protocol for behavioral assessment: validation for longitudinal study of neurological dysfunction in mice.

  2001cited by this paper
• Development of SHIRPA to characterise the phenotype of gene-targeted mice.

  2001cited by this paper
• Spontaneous Hemorrhagic Stroke in a Mouse Model of Cerebral Amyloid Angiopathy

  2001cited by this paper
• Involvement of EphA2 in the formation of the tail notochord via interaction with ephrinA1.

  2001cited by this paper
• Transgenic and knockout databases: behavioral profiles of mouse mutants.

  2001cited by this paper
• Trans-NIH neuroscience initiatives on mouse phenotyping and mutagenesis

  2001cited by this paper
• Behavioral disturbances without amyloid deposits in mice overexpressing human amyloid precursor protein with Flemish (A692G) or Dutch (E693Q) mutation.

  2000cited by this paper
• Testing of SHIRPA, a mouse phenotypic assessment protocol, on Dmdmdx and Dmdmdx3cv dystrophin-deficient mice

  2000cited by this paper
• Chapter 4.3 Motor performance of spontaneous murine mutations with cerebellar atrophy

  1999cited by this paper
• Use of SHIRPA and discriminant analysis to characterise marked differences in the behavioural phenotype of six inbred mouse strains.

  1999cited by this paper
• Association of microglia with amyloid plaques in brains of APP23 transgenic mice.

  1999cited by this paper
• Prolonged exposure to an augmented acoustic environment ameliorates age-related auditory changes in C57BL/6J and DBA/2J mice.

  1999cited by this paper
• Early Phenotypic Changes in Transgenic Mice That Overexpress Different Mutants of Amyloid Precursor Protein in Brain*

  1999cited by this paper
• Handbook of molecular-genetic techniques for brain and behavior research

  1999cited by this paper
• Neuron loss in APP transgenic mice

  1998cited by this paper
• 5-Hydroxytryptophan-induced myoclonus in guinea pigs: mediation through 5-HT1/2 receptor subtypes.

  1998cited by this paper
• Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment

  1997cited by this paper
• Neurobehavioral evaluation of lurcher mutant mice during ontogeny.

  1997cited by this paper
• Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology.

  1997cited by this paper
• A novel presenilin 1 mutation resulting in familial Alzheimer's disease with an onset age of 29 years.

  1996cited by this paper
• Differential roles of cerebellar cortex and deep cerebellar nuclei in the learning of the equilibrium behavior: studies in intact and cerebellectomized lurcher mutant mice.

  1995cited by this paper
• Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins.

  1995cited by this paper
• Molecular and phenotypic characterization of a new mouse insertional mutation that causes a defect in the distal vertebrae of the spine.

  1995cited by this paper
• The Alzheimer's Aβ peptide induces neurodegeneration and apoptotic cell death in transgenic mice

  1995cited by this paper
• Neurologic signs in Alzheimer's disease. Results of a prospective clinical and neuropathologic study.

  1992cited by this paper
• Cumulative risks of developing extrapyramidal signs, psychosis, or myoclonus in the course of Alzheimer's disease.

  1991cited by this paper
• The neurologic examination in patients with probable Alzheimer's disease.

  1987cited by this paper

• Sex-specific changes in energy demand during the preplaque stage in a transgenic Alzheimer’s mouse model

  2025cites this paper
• Neuroprotection by chronic administration of Fluoroethylnormemantine (FENM) in mouse models of Alzheimer's disease

  2025cites this paper
• Unraveling the mystery of citrate transporters in Alzheimer's disease: An updated review.

  2025cites this paper
• Continuous locomotor activity monitoring to assess animal welfare following intracranial surgery in mice

  2024cites this paper
• Reversal of cell, circuit and seizure phenotypes in a mouse model of DNM1 epileptic encephalopathy

  2023cites this paper
• Bace1 Deletion in the Adult Reverses Epileptiform Activity and Sleep–wake Disturbances in AD Mice

  2023cites this paper
• Reversal of cell, circuit and seizure phenotypes in a mouse model of DNM1 epileptic encephalopathy

  2023cites this paper
• Clasping, Ledge-score Coordination and Early Gait Impairments as Primary Behavioural Markers of Functional Impairment in Alzheimer's Disease.

  2022cites this paper
• Increased KV2.1 Channel Clustering Underlies the Reduction of Delayed Rectifier K+ Currents in Hippocampal Neurons of the Tg2576 Alzheimer’s Disease Mouse

  2022cites this paper
• Neuronal Network Excitability in Alzheimer’s Disease: The Puzzle of Similar versus Divergent Roles of Amyloid β and Tau

  2021cites this paper
• The Neuroprotective Effect of Short Chain Fatty Acids Against Sepsis-Associated Encephalopathy in Mice

  2021cites this paper
• Trans-synaptic spreading of alpha-synuclein pathology through sensory afferents leads to sensory nerve degeneration and neuropathic pain

  2021cites this paper
• Survival Bias and Crosstalk between Chronological and Behavioral Age: Age- and Genotype-Sensitivity Tests Define Behavioral Signatures in Middle-Aged, Old, and Long-Lived Mice with Normal and AD-Associated Aging

  2021cites this paper
• SHIRPA as a Neurological Screening Battery in Mice

  2021cites this paper
• Dietary-challenged mice with Alzheimer-like pathology show increased energy expenditure and reduced adipocyte hypertrophy and steatosis

  2021cites this paper
• Trans-synaptic spreading of alpha-synuclein pathology through sensory afferents leads to sensory nerve degeneration and neuropathic pain

  2021cites this paper
• Behavioural and psychological symptoms of dementia in mouse models of Alzheimer's disease-related pathology: Running title: BPSD in Alzheimer's disease models.

  2020cites this paper
• Chia seeds as a potential cognitive booster in the APP23 Alzheimer’s disease model

  2020cites this paper
• Behavioral and electrophysiological evidence for a neuroprotective role of aquaporin-4 in the 5xFAD transgenic mice model

  2020cites this paper
• Effects of corticosterone injections in mid-to-late mouse postnatal development on adult motor activity and coordination.

  2020cites this paper
• Anti-amyloid-β protein agents for the treatment of Alzheimer’s disease: an update on emerging drugs

  2020cites this paper
• Alcohol Drinking Exacerbates Neural and Behavioral Pathology in the 3xTg-AD Mouse Model of Alzheimer’s Disease

  2019cites this paper
• Analysis of Motor Function in the Tg4-42 Mouse Model of Alzheimer’s Disease

  2019cites this paper
• Prenatal noise stress aggravates cognitive decline and the onset and progression of beta amyloid pathology in a mouse model of Alzheimer's disease.

  2019cites this paper
• Investigation of neuronal activity in a murine model of Alzheimer’s disease using in vivo two-photon calcium imaging

  2019cites this paper
• Alzheimer-like amyloid and tau alterations associated with cognitive deficit in temporal lobe epilepsy.

  2019cites this paper
• Investigating the role of Amyloid Precursor-Like Protein 2 in Motor Neurone Disease

  2019cites this paper
• Amyloid β-Induced Upregulation of Nav1.6 Underlies Neuronal Hyperactivity in Tg2576 Alzheimer’s Disease Mouse Model

  2019cites this paper
• What's New on Alzheimer's Disease? Insights From AD Mouse Models

  2019cites this paper
• Behavioral Screening for Toxicology and Safety Pharmacology

  2018cites this paper
• Development of high-throughput, non-invasive behavioural and cognitive tests in mice to uncover new mechanisms of abnormal cognition and behaviour

  2018cites this paper
• Epilepsy in Models of Alzheimer’s Disease

  2017cites this paper
• Seizure susceptibility in the APP/PS1 mouse model of Alzheimer's disease and relationship with amyloid β plaques.

  2017cites this paper
• Molecular Mechanisms of Synaptic Plasticity and Memory and Their Dysfunction in Alzheimer's Disease

  2017cites this paper
• APP Causes Hyperexcitability in Fragile X Mice

  2016cites this paper
• Behavioral characterization of CD36 knockout mice with SHIRPA primary screen.

  2016cites this paper
• Increased Epileptiform EEG Activity and Decreased Seizure Threshold in Arctic APP Transgenic Mouse Model of Alzheimer's Disease.

  2016cites this paper
• Network abnormalities and interneuron dysfunction in Alzheimer disease

  2016cites this paper
• Corticothalamic network dysfunction and behavioral deficits in a mouse model of Alzheimer's disease.

  2016cites this paper
• Emerging Link between Alzheimer's Disease and Homeostatic Synaptic Plasticity

  2016cites this paper
• Seizure-Induced Regulations of Amyloid-β, STEP61, and STEP61 Substrates Involved in Hippocampal Synaptic Plasticity

  2016cites this paper
• Genetic Mapping in Mice Reveals the Involvement of Pcdh9 in Long-Term Social and Object Recognition and Sensorimotor Development.

  2015cites this paper
• Seizures in Alzheimer's disease.

  2015influential citation
• Neuronal Network Oscillations in Neurodegenerative Diseases

  2015cites this paper
• Amyloid-beta / Fyn – Induced Synaptic , Network , and Cognitive Impairments Depend on Tau Levels in Multiple Mouse Models of Alzheimer ’ s Disease

  2015cites this paper
• Early Onset of Hypersynchronous Network Activity and Expression of a Marker of Chronic Seizures in the Tg2576 Mouse Model of Alzheimer’s Disease

  2015cites this paper
• Investigating the impact of anaesthesia and surgery on Alzheimer's disease and the potential therapeutic role of Statin

  2015cites this paper
• Neuronal hyperactivity – A key defect in Alzheimer's disease?

  2015cites this paper
• As A New Potential Target In Alzheimer ’ s Disease

  2015cites this paper
• Neurobehavioral Anomalies in the Pitx3/ak Murine Model of Parkinson’s Disease and MPTP

  2015cites this paper
• Altered Theta Oscillations and Aberrant Cortical Excitatory Activity in the 5XFAD Model of Alzheimer's Disease

  2015cites this paper
• p38 MAP kinase-mediated NMDA receptor-dependent suppression of hippocampal hypersynchronicity in a mouse model of Alzheimer’s disease

  2014cites this paper
• Therapeutic and functional studies in animal models of Alzheimer's disease

  2014cites this paper
• GeneticSuppressionofTransgenicAPPRescues HypersynchronousNetworkActivityinaMouseModelof Alzeimer'sDisease

  2014cites this paper
• Enhancing the value of psychiatric mouse models; differential expression of developmental behavioral and cognitive profiles in four inbred strains of mice.

  2014cites this paper
• On the Neurobiology of Physical Activity in Mice and Human : In search of Eating Disorders Determinants

  2014cites this paper
• Evaluation of tau as a target for Alzheimer disease and other conditions with epileptiform activity

  2014cites this paper
• Étude de la plasticité synaptique hippocampique induite par un apprentissage contextuel

  2014cites this paper
• Lithium Chloride Therapy Fails to Improve Motor Function in a Transgenic Mouse Model of Machado-Joseph Disease

  2014cites this paper
• Genetic Suppression of Transgenic APP Rescues Hypersynchronous Network Activity in a Mouse Model of Alzeimer's Disease

  2014influential citation
• Behavioral and EEG changes in male 5xFAD mice.

  2014cites this paper
• DESEMPENHO LOCOMOTOR DE CAMUNDONGOS COM INFECÇÃO CHAGÁSICA EXPERIMENTAL AGUDA

  2013cites this paper
• Shared cognitive and behavioral impairments in epilepsy and Alzheimer's disease and potential underlying mechanisms.

  2013cites this paper
• Regulatory roles of the NMDA receptor GluN3A subunit in locomotion, pain perception and cognitive functions in adult mice

  2013cites this paper
• Análise fisiológica e comportamental de modelos animais desenvolvidos geneticamente para o estudo da ansiedade e da doença de Alzheimer

  2013cites this paper
• Comprehensive behavioral characterization of an APP/PS-1 double knock-in mouse model of Alzheimer's disease

  2013cites this paper
• Cannabinoid receptor 1 deficiency in a mouse model of Alzheimer's disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition.

  2013cites this paper
• Sodium Channel Cleavage Is Associated with Aberrant Neuronal Activity and Cognitive Deficits in a Mouse Model of Alzheimer's Disease

  2013cites this paper
• Blockade of CXCR1/2 chemokine receptors protects against brain damage in ischemic stroke in mice

  2013cites this paper
• Effects of isoflurane-induced anaesthesia on cognitive performance in a mouse model of Alzheimer's disease: A randomised trial in transgenic APP23 mice

  2013cites this paper
• The 5XFAD mouse model: a tool for genetic modulation of Alzheime's disease pathology

  2012cites this paper
• Identifying neuromuscular abnormalities in ThoBTB3 deficient mice, using the phenotypic assessment protocol - SHIRPA

  2012cites this paper
• Neurologic function during developmental and adult stages in Dab1(scm) (scrambler) mutant mice.

  2012cites this paper
• Brain regions and genes affecting myoclonus in animals.

  2012cites this paper
• Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model.

  2012cites this paper
• Down Syndrome and Dementia: Seizures and Cognitive Decline

  2012cites this paper
• Cognitive and non-cognitive behaviors in the triple transgenic mouse model of Alzheimer's disease expressing mutated APP, PS1, and Mapt (3xTg-AD).

  2012cites this paper
• Neurologic and motor dysfunctions in APP transgenic mice

  2012cites this paper
• Geriatric epilepsy: research and clinical directions for the future.

  2011cites this paper
• Brain regions and genes affecting limb-clasping responses.

  2011influential citation
• Amyloid-β/Fyn–Induced Synaptic, Network, and Cognitive Impairments Depend on Tau Levels in Multiple Mouse Models of Alzheimer's Disease

  2011cites this paper
• Aligning strategies for using EEG as a surrogate biomarker: a review of preclinical and clinical research.

  2011cites this paper
• Early molecular and synaptic dysfunctions in the prodromal stages of Alzheimer’s disease: focus on TNF-α and IL-1β

  2011cites this paper
• Effect of a high fat diet on a mouse model of Alzheimer's disease

  2011cites this paper
• Increased cocaine self-administration in M4 muscarinic acetylcholine receptor knockout mice

  2011cites this paper
• A perfect storm: Converging paths of epilepsy and Alzheimer’s dementia intersect in the hippocampal formation

  2011cites this paper
• Amyloid-/Fyn-InducedSynaptic,Network,andCognitive ImpairmentsDependonTauLevelsinMultipleMouse ModelsofAlzheimer'sDisease

  2011cites this paper
• Mechanisms of Neural and Behavioral Dysfunction in Alzheimer’s Disease

  2011cites this paper
• Amyloid-β–induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks

  2010cites this paper
• Behavioral Screening for Toxicology

  2010cites this paper
• Alzheimer’s Disease and Neuronal Network Activity

  2010cites this paper
• Development of a Murine Model of Neuroparacoccidioidomycosis

  2010cites this paper
• Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models.

  2010cites this paper
• mpaired behavior of female tg-ArcSwe APP mice in the IntelliCage : longitudinal study

  2010cites this paper
• Inflammatory changes in the central nervous system are associated with behavioral impairment in Plasmodium berghei (strain ANKA)-infected mice.

  2010cites this paper
• Transgenic Alzheimer Mice Have a Larger Minimum Alveolar Anesthetic Concentration of Isoflurane than Their Nontransgenic Littermates

  2010cites this paper
• How Many Ways Can Mouse Behavioral Experiments Go Wrong? Confounding Variables in Mouse Models of Neurodegenerative Diseases and How to Control Them

  2010cites this paper
• Alzheimer's Disease and Down Syndrome Rodent Models Exhibit Audiogenic Seizures

  2010cites this paper
• Cognitive and non‐cognitive behaviors in an APPswe/PS1 bigenic model of Alzheimer’s disease

  2009cites this paper
• Improved Behavioral Response as a Valid Biomarker for Drug Screening Program in Transgenic Rodent Models of Tauopathies

  2009cites this paper